Use of nonobese diabetic mice to understand human type 1 diabetes
- PMID: 20723819
- PMCID: PMC2925291
- DOI: 10.1016/j.ecl.2010.05.001
Use of nonobese diabetic mice to understand human type 1 diabetes
Abstract
In 1922, Leonard Thompson received the first injections of insulin prepared from the pancreas of canine test subjects. From pancreatectomized dogs to the more recent development of animal models that spontaneously develop autoimmune syndromes, animal models have played a meaningful role in furthering diabetes research. Of these animals, the nonobese diabetic (NOD) mouse is the most widely used for research in type 1 diabetes (T1D) because the NOD shares several genetic and immunologic traits with the human form of the disease. In this article, the authors discuss the similarities and differences in NOD and human T1D and the potential role of NOD mice in future preclinical studies, aiming to provide a better understanding of the genetic and immune defects that lead to T1D.
Copyright 2010 Elsevier Inc. All rights reserved.
References
-
- Like AA, Butler L, Williams RM, Appel MC, Weringer EJ, Rossini AA. Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes. 1982;31:7–13. - PubMed
-
- Like AA, Kislauskis E, Williams RR, Rossini AA. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science (New York, NY. 1982;216:644–646. - PubMed
-
- Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken dobutsu. 1980;29:1–13. - PubMed
-
- Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nature medicine. 1999;5:601–604. - PubMed
-
- Roep BO, Atkinson M. Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia. 2004;47:1650–1656. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
